Colossal Biosciences
Colossal Biosciences works on CRISPR technology applications that would allow to bring back extinct species. The firm also aims to help protect endangered species such as elephants.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
- Combo news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
Funding Round
Funding Amount
Post-Money Valuation
$ Share Price
Series B31 Jan 2023
***
***
$...
Venture 3 Oct 2022
***
***
$...
Series A 9 Mar 2022
***
***
$...
Seed 6 May 2021
***
***
$...
*** - To view the data, please log into your account or create a new one.
Investors
CIA
JAZZ Venture Partners
Draper Associates
Breyer CapitalNews related to Colossal Biosciences
Colossal Biosciences • 1 Feb 2023Colossal Biosciences hopes to resurrect the woolly mammoth in 4 ...
Colossal Biosciences hopes to resurrect the woolly mammoth in 4 years ...
https://www.msn.com/en-us/news/technology/colossal-biosciences-hopes-to-resurrect-the-woolly-mammoth-in-4-years/ar-AA16Y5w9